Triumvira Immunologics Company
Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.
Technology:
Cell-based gene therapy
Industry:
Private
Headquarters:
Austin, Texas, United States
Founded Date:
2015-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
100000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-17
Last Funding Type:
Series A
Register and Claim Ownership